Tolecizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tolecizumab, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma [Phase 2]